Cidara Therapeutics (CDTX) Tops Q3 EPS by 21c
Cidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($0.73), $0.21 better than the analyst estimate of ($0.94).
For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.
Cidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($0.73), $0.21 better than the analyst estimate of ($0.94).
For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.